LGALS3 and autosomal dominant polycystic kidney disease: ,34 Elevated circulating levels of galectin-3 are linked to CKD progression and myocardial dysfunction, and preclinical data suggest that galectin-3 inhibition may ameliorate cardiac abnormalities in ADPKD.13